CLINICAL_TRIALS
trial_result
· 2018-11-14
Clinical Trial Update: BI 409306 in Patients With Cognitive Impairment Due to Alzheimer's Disease. [Phase 2]
Summary
Phase 2 clinical trial update for BI 409306 in cognitive impairment due to Alzheimer’s disease; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Alzheimer Disease | Phase 2 | Status: COMPLETED | Results posted: 2018-11-14